SBC Medical Group Holdings Inc
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SBC Medical Group Holdings Incorporated | ||
| Dated: March 28, 2025 | /s/ Yoshiyuki Aikawa | |
|---|---|---|
| Name: | Yoshiyuki Aikawa | |
| Title: | Director, Chairman and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Position | Date |
|---|---|---|
| /s/ Yoshiyuki Aikawa | Director, Chairman and Chief Executive Officer | March 28, 2025 |
| Yoshiyuki Aikawa | (Principal Executive Officer) | |
| /s/ Ryoji Murata | Chief Financial Officer | March 28, 2025 |
| Ryoji Murata | (Principal Financial and Accounting Officer) | |
| /s/ Yuya Yoshida | Director and Chief Operating Officer | March 28, 2025 |
| Yuya Yoshida | ||
| /s/ Ken Edahiro | Independent Director | March 28, 2025 |
| Ken Edahiro | ||
| /s/ Mike Sayama | Independent Director | March 28, 2025 |
| Mike Sayama | ||
| /s/ Fumitoshi Fujiwara | Independent Director | March 28, 2025 |
| Fumitoshi Fujiwara | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.